NASCIT

NASCIT is a special situations investment trust dedicated to active value and growth investments to achieve positive absolute returns for shareholders.

[NASCIT @NASCInvTrust]

⭐ Board remains confident that the Group will deliver adj PBT for the full year in line with expectations

https://t.co/HR4A0ZYrdV

[NASCIT @NASCInvTrust]

☑️#NAS investee #RST provides a trading update for the 4 months ended 30 April 2026 ahead of its AGM to be held later today

📈 Revenues increased significantly due to contributions from acquisitions and organic growth
📊 Operating margins remained strong across each division...

[NASCIT @NASCInvTrust]

and in line with strategy
🧩 Completion of 3 bolt-on acquisitions for an aggregate cash consideration of £3.5m - the Group continues to review further acquisitions opportunities
💷 £20m share buyback announced in March has launched

[NASCIT @NASCInvTrust]

✅#NAS investee #GLE provides a trading update for the 11 weeks ending 24 April 2026

✔️ The Board expects Adj Group PBT for the year ending 30 June 2026 to be in line with market consensus

https://t.co/OfHY4NcBDs

[NASCIT @NASCInvTrust]

✅The Board remains optimistic for the Trust's performance in FY 2027 as corporate activity and share buy backs continue to drive improvement in NAV

https://t.co/YNAKZitF7e

[NASCIT @NASCInvTrust]

☑️#NAS announces its final results for the year ended 31 January 2026

📈 In the year the Company repurchased 1,396,241 shares at a discount to NAV and cancelled them, increasing value for shareholders
💷 Strong cash position of c. £44m, including US Treasury Bills

[NASCIT @NASCInvTrust]

plan. Her appointment reflects our commitment to building a leadership team capable of delivering our ambitious growth targets.”

https://t.co/IfZaboOqkI

[NASCIT @NASCInvTrust]

☑️#NAS investee #EKF - Helen Jones FCA appointed as CFO

👥Helen joins the Board and assumes the role with immediate effect
✅Highly experienced CFO with 20+ years of expertise in finance, operations, and strategic transactions within high-growth, tech-driven AIM-listed companies

[NASCIT @NASCInvTrust]

execute on our five-year development plan for accelerated growth. Helen's track record in listed healthcare technology businesses, her experience executing complex transactions, and her capital markets expertise make her an excellent fit for EKF as we accelerate our five-year...

[NASCIT @NASCInvTrust]

https://t.co/dDkKCdSVkT

[NASCIT @NASCInvTrust]

☑️#NAS investee #PINE final results

📈 Revenue up 29.8% to £40.5m
📊 Recurring revenue increased to £33.7m (83.2% of total revenue)
📈 Underlying EBITDA up 17.1% to £16.4m
🌐 Strong strategic and operational progress across UK & International markets

[NASCIT @NASCInvTrust]

🌎Good momentum in North America; system testing underway in US dealerships
🧩Seez AI integration driving benefits across new and existing customers
✔️Board is confident in the Group's outlook and expects underlying EBITDA for FY26 to be in line with market expectations

[NASCIT @NASCInvTrust]

✅ Submission of Technical Review for the CE marking of kidneyintelX.dkd completed

🔗https://t.co/bcv2oQLmAd

[NASCIT @NASCInvTrust]

☑️#NAS investee #RENX - key regulatory milestones achieved in support of scaling of kidneyintelX.dkd

🥼 New laboratory enables 3.5x increase in testing volumes at reduced operating cost
⭐ Positions #RENX to efficiently meet growing demand and support broader commercial adoption

[NASCIT @NASCInvTrust]

https://t.co/ttt6WhHoSb

[NASCIT @NASCInvTrust]

☑️#NAS investee #AVG announces strong nuclear orders

🛒 Its AES division has secured orders worth more than £10m for nuclear applications in the YTD
⚡ Includes a £3m contract for a Reactor Water Cleanup Pump for the Iberdrola Cofrentes Nuclear Power Plant

[NASCIT @NASCInvTrust]

well advanced developing prototypes for one of the world's leading SMR companies and we expect this to be just the start of a significant increase in market activity across the industry."